22 Sep 2021 Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study Member news
09 Sep 2021 Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology Member news
01 Sep 2021 ExeVir announces first patient enrolled in phase 1b/2 clinical study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19 Member news
30 Aug 2021 Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004 Member news
17 Aug 2021 Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies Member news
28 Jul 2021 Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017 Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
